How long did you take this medication to work?
sponsored
Spasmonil Plus indications
sponsored
Gastro-intestinal distress due to spasm
Painful menstruation Smooth muscle spasm
Spasmonil Plus dosage
1 tab bid-tid.
Spasmonil Plus side effects
Dry mouth, thirst, dizziness, fatigue,
sedation, blurred vision, rash, constipation
loss of appetite, nausea, headache
Spasmonil Plus contraindications
Not used in : Obstructive disease of gastro-intestinal tract
Urinary tract disorder
Severe ulceration of the colon
Gastric inflammation or inflammatory bowel disease
Glaucoma
Peptic ulceration
Aspirin or anti-inflammatory drug sensitive asthma
Liver or kidney disorder
Children below 14 years
Active ingredient matches for Spasmonil Plus:
Dicyclomine/Mefenamic Acid in India.
Dicyclomine/Dicycloverine Hcl/Mefenamic Acid
Dicyclomine/Dicycloverine hydrochloride/mefenamic acid in India.
| Unit description / dosage (Manufacturer) | Price, USD |
| 10's | $ 0.17 |
| Spasmonil Plus 10+250 Tablet | $ 0.02 |
| Spasmonil Plus Dicyclomine 10 mg, Mefenamicacid 250 mg. TAB / 10 | $ 0.17 |
| SPASMONIL PLUS TABLET 1 strip / 10 tablets each (Cipla Ltd) | $ 0.27 |
| SPASMONIL PLUS tab 10's (Cipla) | $ 0.17 |
| Spasmonil Plus Tablet (Cipla Ltd) | $ 0.03 |
List of Spasmonil Plus substitutes (brand and generic names): | |
| SPASMOGEM | |
| Spasmogem 10 mg/250 mg Tablet (St Morrison) | $ 0.03 |
| SPASNIC (India) | |
| 10's (Daksh Pharma) | $ 0.22 |
| Spasnic 10+250 Tablet (Daksh Pharma) | $ 0.02 |
| Spasnic Mefenamic acid 250 mg, Dicyclomine 10 mg. TAB / 10 (Daksh Pharma) | $ 0.22 |
| SPASNIC tab 10's (Daksh Pharma) | $ 0.29 |
| Spasnic Mefenamic acid 250 mg, Dicyclomine 10 mg. TAB / 10 (Daksh Pharma) | $ 0.22 |
| Spastra (India) | |
| Spastra Mefenamic acid 250 mg, dicyclomine hydrochloride 20mg. TAB / 10 (Mestra) | $ 0.27 |
| SPASTRA 20MG/250MG TABLET 1 strip / 10 tablets each (Mestra) | $ 2.71 |
| SPASTRA tab 10's (Mestra) | $ 0.27 |
| Spastra 20mg/250mg Tablet (Mestra) | $ 0.27 |
| SPASTROL M | |
| SPASTROL M 10MG/250MG TABLET 1 strip / 10 tablets each (Seagull Labs (I) Pvt Ltd) | $ 0.22 |
|
sponsored
| |
| Spastrol M 10 mg/250 mg Tablet (Seagull Pharmaceutical Pvt Ltd) | $ 0.02 |
| Spaswel (India) | |
| Spaswel Dicyclomine hydrochloride 20mg, paracetamol 500 mg. TAB / 10 (Treatwell) | $ 0.27 |
| SPASWEL tab 10's (Treatwell) | $ 0.27 |
| SPASZO (India) | |
| 10's (Zodley Pharmaceuticals Pvt Ltd) | $ 0.22 |
| Spaszo 10+250 Tablet (Zodley Pharmaceuticals Pvt Ltd) | $ 0.02 |
| Spaszo Mefenamic acid 250 mg, Dicyclomine 10 mg. TAB / 10 (Zodley Pharmaceuticals Pvt Ltd) | $ 0.22 |
| SPASZO tab 10's (Zodley Pharmaceuticals Pvt Ltd) | $ 0.22 |
| Spaszo Mefenamic acid 250 mg, Dicyclomine 10 mg. TAB / 10 (Zodley Pharmaceuticals Pvt Ltd) | $ 0.22 |
| Spazwin Dps (India) | |
| Spazwin Dps Dicyclomine hydrochloride 10mg, activated dimeticone 40mg, papain 8 mg/1 mL. O-DPS / 15ml (Waves-Biotech) | |
| SPAZWIN DPS oral drops 15ml (Waves-Biotech) | |
| Speedex-Spas Tablet | |
| Speedex-Spas Tablet (Pharmasynth Formulations Ltd) | $ 0.04 |
| Swispas Inj (India) | |
| Swispas Inj 10mg/ml AMP / 2ml (Ind-Swift) | $ 0.04 |
| Swispas Inj 10mg/ml VIAL / 10ml (Ind-Swift) | $ 0.24 |
| 10 mg x 1 mL x 2ml (Ind-Swift) | $ 0.04 |
| 10 mg x 1 mL x 10ml (Ind-Swift) | $ 0.24 |
| SWISPAS INJ inj 10 mg x 1 mL x 2ml (Ind-Swift) | $ 0.04 |
| SWISPAS INJ inj 10 mg x 1 mL x 10ml (Ind-Swift) | $ 0.24 |
| TEVNIC (India) | |
| 10's (Zubit) | |
| Tevnic Mefenamic acid 250 mg, Dicyclomine 10 mg. TAB / 10 (Zubit) | |
| TEVNIC tab 10's (Zubit) | |
| Tevnic Mefenamic acid 250 mg, Dicyclomine 10 mg. TAB / 10 (Zubit) | |
| Trigand-D Inj | |
| Trigand-D Inj 10mg/ml INJ / 2ml | $ 0.05 |
| TYTO-SPAS (India) | |
| TYTO-SPAS tab 10's (TNT) | $ 0.29 |
| Ventra-P (India) | |
| Ventra-P Dicyclomine hydrochloride 20mg, paracetamol 325 mg. TAB / 10 (Ventus) | |
| VENTRA-P tab 10's (Ventus) | |
| Vermef-D (India) | |
| Vermef-D Dicyclomine hydrochloride 10mg, mefenamic acid 250 mg. TAB / 10 (Ventus) | |
| VERMEF-D tab 10's (Ventus) | $ 2.77 |
| Westal Dps (India) | |
| Westal Dps Dicyclomine hydrochloride 10mg, activated dimeticone 40mg. O-DPS / 10ml (Edelweiss) | |
| WESTAL DPS oral drops 10ml (Edelweiss) | |
| XIONSPAS (India) | |
| 200's (Xieon Lifesciences Pvt. Ltd.) | $ 4.46 |
| Xionspas 10+250 Tablet (Xieon Lifesciences Pvt. Ltd.) | $ 0.02 |
See 287 substitutes for Spasmonil Plus | |
References
- DailyMed. "MEFENAMIC ACID: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "mefenamic acid". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- PubChem. "dicyclomine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Spasmonil Plus are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Spasmonil Plus. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yet2 consumers reported price estimates
Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?The below mentioned numbers have been reported by ndrugs.com website users about whether the Spasmonil Plus drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
| Users | % | ||
|---|---|---|---|
| Not expensive | 1 | 50.0% | |
| Expensive | 1 | 50.0% | |
Consumer reported time for results
No survey data has been collected yet3 consumers reported age
| Users | % | ||
|---|---|---|---|
| 30-45 | 2 | 66.7% | |
| 16-29 | 1 | 33.3% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
